The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Share Option Scheme and Grant to PDMR

4 Dec 2017 07:00

RNS Number : 2141Y
Cronin Group PLC
04 December 2017
 

4 December 2017

Cronin Group Plc

("Cronin" or the "Company")

Adoption of New Share Option Scheme

and

Grant of Options to a PDMR

 

Cronin Group Plc, the AIM listed company focusing on digitizing chemistry, announces the adoption of the Cronin Group Plc Share Option Plan 2017 (the "Plan") and the grant of options to all employees of its subsidiary, Cronin 3D Limited, including a person discharging managerial responsibilities ("PDMR").

 

The Plan is being introduced to recruit, retain and incentivise Directors and employees of the Company and its subsidiaries (the "Group"). The number of options that may be awarded under the Plan is limited to a maximum number of new ordinary shares of 0.01p each in the Company ("Ordinary Shares") representing 11 per cent. of the Company's issued share capital, and may be issued as tax-effective enterprise management incentives where appropriate.

The Board has approved the terms of the Plan and, authorised an initial award of options to employees on 1 December 2017 (the "Date of Grant") over 1,936,667 Ordinary Shares at an exercise price of 2.13p (being the closing price on 30 November 2017, the business day preceding the Date of Grant). The award represents approximately 0.35 per cent. of the Company's issued share capital.

Of the 1,936,667 options granted under the Plan, 677,871 vest on the date of grant. The balance vest in monthly instalments until either three years from the Date of Grant, or in the case of certain longer serving employees, from the earlier date of three years from the end of each of the employees' respective historic probation periods. The options are all exercisable for 10 years from the Date of Grant and the Plan will expire on 30 November 2027.

Within the award of options referred to above, Steve Coles, the Company's Chief Technology Officer, who is identified as a PDMR, has been granted options over a total of 1,666,667 Ordinary Shares, of which 648,148 vest on the Date of Grant and vesting of the balance is in monthly instalments thereafter until 1 October 2019.

 

For further information:

Cronin Group Plc

www.croningroupplc.com

Mark Warne, Executive Chairman

T: 0141 465 6871

Stockdale Securities Limited

T: 020 7601 6100

Tom Griffiths/Edward Thomas

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKMMGZRMGGNZM
Date   Source Headline
24th Jan 20228:50 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSHolding(s) in Company
20th Jan 202212:15 pmRNSResult of General Meeting
20th Jan 20227:00 amRNSResult of Open Offer - Correction
19th Jan 202211:30 amRNSResult of Open Offer
4th Jan 20221:30 pmRNSPosting of Circular and Notice of GM
29th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Dec 20217:00 amRNSPlacing, Subscription and Open Offer
17th Dec 20215:00 pmRNSBusiness Update and Financing
22nd Oct 20217:00 amRNSAppointment of new Scientific Advisory Board
21st Oct 20218:00 amRNSDigitalGlassware® platform trial with Aurigene
28th Sep 20217:00 amRNSCollaboration
22nd Sep 20217:00 amRNSHalf Year Results
14th Sep 202110:30 amRNSNotice of Half Year Results
8th Sep 20211:30 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSAdvisory Board Appointment
5th Aug 20217:00 amRNSCollaboration with the University of Cambridge
12th Jul 20217:00 amRNSAppointment of Non-Executive Director
30th Jun 20213:34 pmRNSResult of AGM
22nd Jun 20217:00 amRNSChanges to 2021 AGM Arrangements
17th Jun 20217:00 amRNSCollaboration with the University of Leeds
8th Jun 20213:16 pmRNSPosting of ARA and Updated Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th May 20217:00 amRNSNotice of Results and Investor Presentation
6th May 20213:43 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSCollaboration with the University of Nottingham
11th Mar 20217:00 amRNSCo-distribution agreement with Elemental Machines
9th Mar 20217:00 amRNSDirectorate Change
20th Jan 20217:00 amRNSAgreement with Merck's Life Sciences business
19th Jan 20217:00 amRNSHolding(s) in Company
8th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Dec 202010:30 amRNSGrant of PDMR Options
17th Dec 20207:00 amRNSMulti-year contract with Thieme Chemistry
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSIssue of Shares and Total Voting Rights
19th Oct 20207:00 amRNSDirectorate Changes
16th Oct 20207:00 amRNSStrong adoption of ICSYNTH
2nd Oct 20202:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 20208:00 amRNSGrant of Options
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20201:40 pmRNSHolding(s) in Company
22nd Sep 20204:29 pmRNSHolding(s) in Company
22nd Sep 20204:00 pmRNSHolding(s) in Company
22nd Sep 202010:32 amRNSHolding(s) in Company
15th Sep 20208:08 amRNSIssue of Shares and Total Voting Rights
10th Sep 20207:00 amRNSHalf-year Report
4th Sep 20208:26 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.